About Christoph Schäfer

This author has not yet filled in any details.
So far Christoph Schäfer has created 59 blog entries.

CIS Pharma appoints Dr. Christophe Thommen as new head of research and laboratory operations

Bubendorf, Switzerland, Thursday, December 1, 2016 - CIS Pharma welcomes Dr. Christophe Thommen, who will lead the research team as the new head of research and laboratory operations. Christophe is [...]

CIS Pharma’s solubilization technology comprising cyclosporine A has entered proof of concept phase

Bubendorf, Switzerland, Friday, October 21, 2016 - CIS Pharma’s novel solubilization strategy for hydrophobic drugs has successfully reached the proof of concept phase. The Cellophil® Smart Polymer technology platform creates [...]

CIS Pharma team attends CPhI Worlwide 2016 in Barcelona

Barcelona, Spain, Tuesday to Thursday, October 4 to 6, 2016 – CIS Pharma is attending CPhI Worlwide to meet development partners and licensees during the three-day conference in Barcelona. The [...]

CIS Pharma has successfully concluded the development of novel contact lens coating technology

Bubendorf, Switzerland, Monday, September 5, 2016 - CIS Pharma has concluded the development of a novel contact lens coating technology based on the Cellophil® Smart Polymer platform. The technology has [...]

CIS Pharma to launch new web presence

Bubendorf, Switzerland, Monday, August 1, 2016 - CIS Pharma’s new company website is online. The site was established in collaboration with SKYWEB, a fast-growing start-up incorporated in close proximity to [...]

CIS Pharma has developed contact lens care products based on its new patented technology platform

Bubendorf, Switzerland, Friday, June 16, 2016 - CIS Pharma has developed a novel multipurpose solution for contact lenses. With over 25 years of experience and a track record of several [...]

Approval received for intracameral cefuroxime for antibiotic prophylaxis of endophthalmitis after cataract surgery

Uppsala, Sweden, Mai 24, 2016 – The marketing authorization application for intracameral cefuroxime has been finalized with a positive outcome. The decentralized procedure was led by Sweden as reference member [...]

Development of vial adaptor for preparation of intracameral cefuroxime

Bubendorf, April 10, 2016 – CIS Pharma enters agreement with West Pharma to develop a vial adaptor specific for the preparation and injection of intracameral cefuroxime. The development is innovative [...]

CIS Pharma team attends Pharmapack 2016 in Paris

Paris, France, Wednesday to Thursday, February 10 to 11, 2016 – CIS Pharma is attending CPhI Worlwide to meet development partners and licensees during the two-day conference in Paris. The [...]

CIS Pharma announces the first milestones in its ADC research program are achieved

Bubendorf, Switzerland, Thursday, January 21, 2016 - Proof of concept studies at NBE Therapeutics demonstrated conjugation of CIS Pharma’s Cellophil® Smart Polymer drug carrier to antibodies. Consequently, different linkers [...]